Documenti da scaricare

• Cell-Free DNA Analysis for Trisomy Risk Assessment in First-Trimester Twin Pregnancies
• Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18
• Clinical experience of noninvasive prenatal testing with cell-free DNA for fetal trisomies 21, 18, and 13, in a general screenin
• Clinical Utility and Cost of Non-Invasive Prenatal Testing with cfDNA Analysis in High Risk Women Based on a U.S. Population
• European non-invasive trisomy evaluation (EU-NITE) study: a multicenter prospective cohort study for non-invasive fetal trisomy
• Fetal Fraction Estimate in Twin Pregnancies Using Directed Cell-Free DNA Analysis
• Fetal Fraction in Maternal Plasma Cell-Free DNA at 11-13 Weeks' Gestation: Effect of Maternal and Fetal Factors
• First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing
• Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma
• Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies
• Incorporating DNA sequencing into current prenatal screening pratice for Down's synadrome
• Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal triso
• Non-invasive prenatal testing with cell-free DNA: US physician attitudes toward implementation in clinical practice
• Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 a
• Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population
• Presentation - Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies
• Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy
• The fetal fraction of cell-free DNA in maternal plasma is not affected by a priori risk of fetal trisomy
• Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method